Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Brain Neoplasms 11Delirium 3Central Nervous System Diseases 2Supratentorial Neoplasms 1Spinal Cord Neoplasms 1Pain 1Neuroinflammatory Diseases 1Neurofibromatoses 1Neurocognitive Disorders 1Neoplasms 1Meningioma 1Intracranial Aneurysm 1Hypoxia 1Hydrocephalus 1Headache 1Epilepsy 1Emergence Delirium 1Cerebrovascular Disorders 1Abdominal Neoplasms 1

Interventions

esmolol 1Insulin, Regular, Human 1Insulin 1Indocyanine Green 1Dexmedetomidine 1Cholecalciferol 1Adrenergic alpha-Agonists 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Intracranial Aneurysm × Dexmedetomidine × CNS × Clear all
NCT02563288 2017-07-27

Esmolol Versus Dexmedetomidine During Intracranial Procedures

George Papanicolaou Hospital

Phase 3 Unknown
60 enrolled
CNS

Brain Neoplasms, Intracranial Aneurysm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡